Clare Woodford/LinkedIn
Apr 2, 2026, 13:51
Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
Clare Woodford, Head of Policy and Influencing at The Stroke Association, shared on LinkedIn:
”NICE‘s announcement that people who’ve had a stroke or heart attack and are overweight can access semaglutide on the NHS is an important development in tackling stroke and cardiovascular disease.
1 in 4 stroke survivors go on to have another stroke so this could be another vital resource in the toolbox to prevent more strokes.
Our website has more on stroke and weight loss, and steps to maintain a healthy weight.”
Stay updated with Hemostasis Today.
-
Apr 2, 2026, 13:53Ahvie Herskowitz: Therapeutic Plasma Exchange as a Precision Cancer Weapon
-
Apr 2, 2026, 13:46Ney Carter Borges: Plaque Erosion Defines a Distinct Mechanistic and Clinical Phenotype in Acute Coronary Syndrome
-
Apr 2, 2026, 13:19John Michael Quinn: Prehospital Whole Blood Remains Critical in Trauma Care
-
Apr 2, 2026, 13:04Dario Bongiovanni: ESC Working Group on Thrombosis Consensus Document Is Now Live
-
Apr 2, 2026, 12:52Ashfa Anwar: While The World Is Editing Genes, Sri Lanka Is Still Thawing Plasma for Hemophilia
-
Apr 2, 2026, 11:48Piotr F. Czempik: Effect of Uremia on Platelet-Mediated Clot Strength in Sepsis
-
Apr 2, 2026, 08:22Chokri Ben Lamine: Laboratory Findings and Management of Severe Type 3 von Willebrand Disease
-
Apr 2, 2026, 08:12Heghine Khachatryan: Dementia at the Intersection of Hematology and Hemostasis
-
Apr 2, 2026, 08:03Thomas Pincez: Revised Guidelines Improve Care for Pediatric Immune Thrombocytopenia